Abstract:Department of Medical and Surgical Neonatology,Bambino Gesu Children’s Hospital, Rome, ItalyReprint requests to: Pietro Cignini, MD“Artemisia” Fetal-Maternal Medical Centre, Department of Prenatal DiagnosisViale Liegi, 45 - 00198 Rome - ItalyTel.: +390685051E-mail: pietrocignini@fastwebnet.itCase reportA 38 years-old woman, gravida 2, para 1 came to theArtemisia Prenatal Diagnosis Centre at 36 weeks ofgestation referred from another institution for the evalu-ation of a fetal mass in the upper-right abdomen. Previ-ous ultrasound scanning performed at 18 and at 22weeks of gestation were negative for fetal abdominalmasses. Amniocentesis performed at 18 weeks of ges-tation was negative and the alfa fetoprotein in the amni-otic fluid was 11243 (n.v. < 26000).The ultrasound scan of the fetus demonstrated a multi-cystic, well-encapsulated mass in the liver of 7×5×5 cmin size (Fig.s 1, 2). No calcifications were observed intothe mass; there were both echolucency and echodenseareas. The Doppler flow investigation of the massdemonstrated a relatively low-absent vascularisation.Others organ near the neoplasm were all normal. No hy-drops was observed. The only remarkable sign was theelevated amniotic fluid index (75° centile). After a multi-disciplinary counselling a caesarean section wasplanned at 37 weeks-of gestation and a strict control ofthe fetus with US was performed until the delivery date.Controls were all negative and polyhydramnios wasequal in all measures. The CS was performed at 35 weeks of gestation due touterine contractions, giving birth to a 2.9 kg female in-fant. Apgar scores were 7 and 8 at 1 and 5 minutes re-spectively. At birth, the abdomen was extremely distend-ed and the baby was referred to the Bambino Gesu Chil-dren’s Hospital that is a tertiary care centre with the di-agnosis of acute abdomen. At physical examination onarrival the abdomen was distended and tender. An ab-dominal X-ray showed an elevated diaphragm and virtu-ally no gas in the bowel. Blood tests were unremarkable.On the hypothesis of a neonatal volvolus secondary toan intestinal atresia an emergency laparotomy was car-ried out. At surgery, a huge mass was found taking up tothree quarters of the abdomen, with the bowel com-pressed but not necrotic. The mass originated from theanterior margin of the liver and was pedunculated. Thepeduncle was suture ligated and the mass resected. Im-mediately after the removal of the mass, acute anaemiaoccurred (Haemoglobin level 5 g/dl), probably fromblood sequestration into the mass itself, leading to pro-found bradycardia and cardiac arrest, successfully treat-ed with prompt cardiopulmonary resususcitation andblood transfusion. At final histology, the mass was com-patible with a mesenchimal amartoma of the liver. Post-operative course was complicated by chylothorax which

A Floating Hydrogel System Capable of Generating CO 2 Bubbles to Diminish Urinary Obstruction After Intravesical Instillation

Floating Hydrogel With Self-Generating Micro-Bubbles For Intravesical Instillation

In Situ Floating Hydrogel for Intravesical Delivery of Adriamycin Without Blocking Urinary Tract

Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release.

Polysaccharide based supramolecular injectable hydrogels for in situ treatment of bladder cancer

Hydrogel: a new material for intravesical drug delivery after bladder cancer surgery

Fetal hepatic mesenchymal hamartoma: a case report.

Injectable 2D-MoS2-integrated adhesive hydrogel for NIR-triggered photothermal and drug-delivery implant in colorectal cancer therapy

Injectable 2D-Mos 2 -Integrated Bioadhesive Hydrogel As Photothermal-Derived and Drug-Delivery Implant for Colorectal Cancer Therapy

Encapsulation of hydroxycamptothecin within porous and hollow poly(l-lactide- co -ε-caprolactone) microspheres as a floating delivery system for intravesical instillation

One-Step In Situ Self-Assembly of Biodegradable Films for Long-Term Intravesical Bladder Cancer Therapy

Phase-changeable and bubble-releasing implants for highly efficient HIFU-responsive tumor surgery and chemotherapy

Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.

Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.

Hydrogel-based formulations for urothelial cancer therapy

Split-thickness skin grafts for coverage of defects in the hand.

Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy

In situ sustained release hydrogel system delivering GLUT1 inhibitor and chemo-drug for cancer post-surgical treatment

Biodegradable and bioactive nHAC/CMs/PLLA scaffolds for bone tissue engineering

Mucoadhesive Thiolated Hyaluronic Acid/Pluronic F127 Nanogel Formation via Thiol-Maleimide Click Reaction for Intravesical Drug Delivery

An engineered hydrogel with low-dose antitumor drugs enhances tumor immunotherapy through tumor interstitial wrap